Andrew Callos
Patrimonio netto: 4 M $ in data 31/08/2026
Patrimonio netto: 4 M $ in data 31/08/2026
Andrew M.
Callos is Chief Commercial Officer & Executive VP at Cytokinetics, Inc. since 2021.
Formerly, Mr. Callos was Vice President-US Cardiology & Metabolic Marketing at Pfizer Inc. and Assistant Vice President-Marketing at Wyeth Pharmaceuticals, Inc. Mr. Callos completed undergraduate education at Drexel University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/08/2026 | 58.555 ( 0,04% ) | 4 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/03/2021 |
| Società | Posizione | Fine |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Vendite & Marketing | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale